Literature DB >> 16982843

A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge.

Vjollca Konjufca1, Soo-Young Wanda, Mark C Jenkins, Roy Curtiss.   

Abstract

Coccidiosis is a ubiquitous disease caused by intestinal protozoan parasites belonging to several distinct species of the genus Eimeria. Cell-mediated immunity (CMI) is critically important for protection against Eimeria; thus, our approach utilizes the bacterial type III secretion system (TTSS) to deliver an antigen directly into the cell cytoplasm of the immunized host and into the major histocompatibility complex class I antigen-processing pathway for induction of CMI and antigen-specific cytotoxic T-lymphocyte responses in particular. To accomplish this goal, Eimeria genes encoding the sporozoite antigen EASZ240 and the merozoite antigen EAMZ250 were fused to the Salmonella enterica serovar Typhimurium effector protein gene sptP in the parental pYA3653 vector, yielding pYA3657 and pYA3658, respectively. SptP protein is secreted by the TTSS of Salmonella and translocated into the cytoplasm of immunized host cells. The host strain chromosomal copy of the sptP gene was deleted and replaced by a reporter gene, xylE. The newly constructed vectors pYA3657 and pYA3658 were introduced into host strain chi8879 (DeltaphoP233 DeltasptP1033::xylEDelta asdA16). This strain is an attenuated derivative of the highly virulent strain UK-1. When strain chi8879(pYA3653) as the vector control and strain chi8879 harboring pYA3657 or pYA3658 were used to orally immunize day-of-hatch chicks, colonization of the bursa, spleen, and liver was observed, with peak titers 6 to 9 days postimmunization. In vitro experiments show that the EASZ240 antigen is secreted into the culture supernatant via the TTSS and that it is delivered into the cytoplasm of Int-407 cells by the TTSS. In vivo experiments indicate that both humoral and cell-mediated immune responses are induced in chickens vaccinated with a recombinant attenuated Salmonella serovar Typhimurium vaccine, which leads to significant protection against Eimeria challenge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982843      PMCID: PMC1698051          DOI: 10.1128/IAI.00851-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  Type III secretion machines: bacterial devices for protein delivery into host cells.

Authors:  J E Galán; A Collmer
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 2.  Bacteriophage-mediated generalized transduction in Escherichia coli and Salmonella typhimurium.

Authors:  N L Sternberg; R Maurer
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 3.  Salmonellae as oral vaccine carriers.

Authors:  F Schödel; R Curtiss
Journal:  Dev Biol Stand       Date:  1995

4.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.

Authors:  S A Ahmed; R M Gogal; J E Walsh
Journal:  J Immunol Methods       Date:  1994-04-15       Impact factor: 2.303

5.  Protective immunization against the intestinal parasite Eimeria acervulina with recombinant coccidial antigen.

Authors:  M C Jenkins; M D Castle; H D Danforth
Journal:  Poult Sci       Date:  1991-03       Impact factor: 3.352

6.  xylE functions as an efficient reporter gene in Streptomyces spp.: use for the study of galP1, a catabolite-controlled promoter.

Authors:  C Ingram; M Brawner; P Youngman; J Westpheling
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

7.  Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes.

Authors:  J O Hassan; R Curtiss
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Acid-sensitive mutants of Salmonella typhimurium identified through a dinitrophenol lethal screening strategy.

Authors:  J W Foster; B Bearson
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

9.  Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells.

Authors:  K Kaniga; S Tucker; D Trollinger; J E Galán
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

10.  Analysis of Eimeria acervulina-induced changes in the intestinal T lymphocyte subpopulations in two chicken strains showing different levels of susceptibility to coccidiosis.

Authors:  H S Lillehoj
Journal:  Res Vet Sci       Date:  1994-01       Impact factor: 2.534

View more
  27 in total

Review 1.  Computational prediction of type III and IV secreted effectors in gram-negative bacteria.

Authors:  Jason E McDermott; Abigail Corrigan; Elena Peterson; Christopher Oehmen; George Niemann; Eric D Cambronne; Danna Sharp; Joshua N Adkins; Ram Samudrala; Fred Heffron
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Giorgio Scarpellini; Ascencion Torres-Escobar; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  The membrane-bound transcriptional regulator CadC is activated by proteolytic cleavage in response to acid stress.

Authors:  Yong Heon Lee; Ji Hye Kim; Iel Soo Bang; Yong Keun Park
Journal:  J Bacteriol       Date:  2008-05-16       Impact factor: 3.490

4.  Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7.

Authors:  Vjollca Konjufca; Mark Jenkins; Shifeng Wang; Maria Dolores Juarez-Rodriguez; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 5.  Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

Authors:  Coral González-Prieto; Cammie F Lesser
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

6.  A Novel Cre Recombinase-Mediated In Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus.

Authors:  Yanlong Jiang; Xing Gao; Ke Xu; Jianzhong Wang; Haibin Huang; Chunwei Shi; Wentao Yang; Yuanhuan Kang; Roy Curtiss; Guilian Yang; Chunfeng Wang
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

7.  A live oral recombinant Salmonella enterica serovar typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens.

Authors:  R R Kulkarni; V R Parreira; Y-F Jiang; J F Prescott
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

8.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

10.  Engineering the Salmonella type III secretion system to export spider silk monomers.

Authors:  Daniel M Widmaier; Danielle Tullman-Ercek; Ethan A Mirsky; Rena Hill; Sridhar Govindarajan; Jeremy Minshull; Christopher A Voigt
Journal:  Mol Syst Biol       Date:  2009-09-15       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.